Hims offers both brand-name Cialis and generic Cialis (tadalafil) that can be sent directly to your home. Brand-name Cialis can be found in doses of 5, 10, and 20 mg, but through Hims, brand-name ...

For Sesame Care’s ED treatments, the company offers Tadalafil — the generic version of the brand name Cialis — and sildenafil, the generic version of the brand Viagra. The company states ...

Let’s cut to the chase: erectile dysfunction (ED) is a common issue, but it’s not the end of the world. Not even on Valentine’s Day. We’ve got the inside scoop from two specialists who know their way ...

Cost: Roman offers both brand-name Cialis and generic Cialis (tadalafil) that you can take as needed or on a daily basis at a lower dose. Here’s a breakdown of what you can expect to pay for ...

The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi’s consumer healthcare business, Opella. Opella had launched the actual use trial (AUT ...

Now, after a review, the FDA’s green light marks a “significant step forward in Opella’s data-driven efforts to switch a PDE-5 inhibitor like Cialis,” Opella’s chief science officer ...

The trial is aimed at transitioning Cialis (tadalafil) from a prescription-only medication to an over-the-counter option. With this decision, the actual use trial can now proceed, marking Cialis ...

Cialis (tadalafil) in the US is currently only available with a prescription. Cialis is a tablet taken to treat erectile dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia ...

Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to support the switch of Cialis ...

WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...